Skip to main content

Together we are beating cancer

Donate now

Lung cancer

Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.

The main symptoms are a cough, shortness of breath and weight loss.

Showing 12 out of 355 results
Cancer Research UK logo

CANCER RESEARCH UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer, and determine the type of lung cancer that develops. Their results were published in this weekїs edition of the journal Cancer Research*. CANCER RESEARCH UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer, and determine the type of lung cancer that develops. Their results were published in this weekїs edition of the journal Cancer Research*.

by Cancer Research UK | News | 20 August 2009

20 August 2009

Cancer Research UK logo

Cancer Research UK scientists have revealed that stem cells become 'activated' in severely damaged lungs and help to repair them, according to a study published in the Proceeding of the National Academy of Sciences* today (Monday). Cancer Research UK scientists have revealed that stem cells become 'activated' in severely damaged lungs and help to repair them, according to a study published in the Proceeding of the National Academy of Sciences* today (Monday).

by Cancer Research UK | News | 25 May 2009

25 May 2009

Cancer Research UK logo

One in 17 British carpenters born in the 1940s will die of mesothelioma - a cancer of the lining of the lung caused by asbestos - according to new research* published in the British Journal of Cancer. One in 17 British carpenters born in the 1940s will die of mesothelioma - a cancer of the lining of the lung caused by asbestos - according to new research* published in the British Journal of Cancer.

by Cancer Research UK | News | 3 March 2009

3 March 2009

Cancer Research UK logo

CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*. CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*.

by Cancer Research UK | News | 1 January 2009

1 January 2009

Cancer Research UK logo

People living in the west of Scotland are 50 per cent more likely to be diagnosed with lung cancer than people living in the rest of the UK, according to a new report revealed at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Tuesday). People living in the west of Scotland are 50 per cent more likely to be diagnosed with lung cancer than people living in the rest of the UK, according to a new report revealed at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Tuesday).

by Cancer Research UK | News | 7 October 2008

7 October 2008

Cancer Research UK logo

New research has revealed that the cost to the NHS in England of treating smoking related illness reached Ј2.7 billion a year by 2007. This equates to Ј50 million every week. New research has revealed that the cost to the NHS in England of treating smoking related illness reached Ј2.7 billion a year by 2007. This equates to Ј50 million every week.

by Cancer Research UK | News | 7 October 2008

7 October 2008

Cancer Research UK logo

A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday). A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday).

by Cancer Research UK | News | 6 October 2008

6 October 2008

Cancer Research UK logo

The National Cancer Research Institute (NCRI) partners funded Ј393m worth of research into cancer in 2006, an increase of Ј135m compared to 2002. But it will warn of slower progress in spend for some cancers, it is announced at the NCRI Cancer Conference in Birmingham today (Sunday). The National Cancer Research Institute (NCRI) partners funded Ј393m worth of research into cancer in 2006, an increase of Ј135m compared to 2002. But it will warn of slower progress in spend for some cancers, it is announced at the NCRI Cancer Conference in Birmingham today (Sunday).

5 October 2008